Hyderabad, India, 2016 – Croissance Clinical Research, a full-fledged CRO providing services for pharmaceutical, bio-technology and medical devices companies, partners with Dr. Reddy’s Laboratories Ltd., The partnership enables Croissance to aid and advance Dr. Reddy’s in research services.
Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Dr Reddy’s Laboratories is a 25–year old company catering to the needs of the pharmaceutical sector. It is among the top three API players in world. Dr Reddy’s, a global pharmaceutical company, has its headquarters located in India. Through its three businesses – Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, and generics, biosimilars, differentiated formulations and NCEs. Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and pediatrics. It has a global presence in more than 100 countries, with subsidiaries in the US, UK, Russia, Germany and Brazil; joint ventures in China, South Africa and Australia; representative offices in 16 countries and third–party distribution set ups in 21 countries.
It is first pharmaceutical company in Asia, outside Japan, to be listed on the NYSE. It is largest player in the custom pharmaceutical services (CPS) business in India.